Skip to main content
Premium Trial:

Request an Annual Quote

James Hinrichs

James Hinrichs has been appointed by Alere as executive vice president and CFO, effective April 6. He takes over from David Teitel, whom the company previously said would transition to a new role. Hinrichs' responsibilities will include finance, procurement, information technology, and shared services. 

He has more than 25 years of experience in financial and executive leadership roles in healthcare and was most recently CFO of CareFusion, which was acquired by Becton Dickinson earlier this month. He previously was senior VP for global customer support and senior VP, controller for CareFusion. Prior to joining that firm, Hinrichs was the CFO of the former clinical technologies and services healthcare supply chain services, and clinical and medical products segments at Cardinal Health.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.